24 A short-term, double-blind clinical study involving 426 patients with peripheral neuropathy of different etiologies, showed statistically meaningful differences between the ALC and placebo groups in terms of mean conduction velocity improvement
1 1 spines per 50 dendrite length for both Nle'-AnglV and dihexa treated neurons
Regulating adaptive immune responses using small molecule modulators of aminopeptidases that process antigenic peptides
GPS content varies significantly among plant species, origins, and extraction methods ( 8 Conclusion GPS demonstrates significant therapeutic potential across a spectrum of diseases, showcasing anti-inflammatory, antioxidant, neuroprotective, hepatoprotective, antidiabetic, antitumor, and skin-related therapeutic properties
An increase of 5 I -nucleotidase activity increases the adenosine formation by hydrolysing AMP to adenosine